₹ 217.58
1.33 (0.62%)
J
Jagsonpal Pharmaceuticals
₹ 217.58
Jagsonpal Pharmaceuticals Share Price Today
Jagsonpal Pharmaceuticals (JAGSNPHARM) share price is trading at ₹217.58 on the NSE as of November 12, 2026 at 03:16 PM, up by 0.62% from its previous close of ₹216.25. In todays trading session JAGSNPHARM reached a high of 218.90 and low of 215.01. The average traded price for today is 217.31. The 50 DMA stands at 227.54 and 200 DMA is at 209.45. Looking at intraday trend, the stock is moving sideways.
Stock Overview
- Symbol : JAGSNPHARM
- Open : ₹216.27
- Previous Close : ₹216.25
- Day's Range : ₹215.01 – ₹218.90
- 52-Week Range : ₹155.00 – ₹264.50
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
JAGSNPHARM Stock Performance
Markets Today
High
218.90
Low
215.01
Open at
216.27
Prev Close
216.25
Volumes
35,928
Avg Price
217.31
Lower Circuit
173.00
Upper Circuit
259.50
Last Traded Details
Quantity
1
Time
15:16:29
Price Movement
Historical Performance
3 M High
251.00
3 M Low
203.41
1 Yr High
264.50
1 Yr Low
155.00
3 Yr High
328.04
3 Yr Low
109.44
5 Yr High
328.04
5 Yr Low
49.20
1-Year Performance
JAGSNPHARM Pros and Cons
Revenue grew from ₹745 Cr to ₹964 Cr YoY — boosted by the 85% stake acquisition in Hospital Supplies
Gross Profit Margin improved from 63.4% to 64.1% YoY — indicating better pricing power or product mix
Hospital Supplies segment consolidated with 85% stake acquired — expanding addressable doctor base to 137,000
Indocap and Lycored maintained #1 market rank — core brands remain dominant in their therapeutic categories
Cash Balance recovered to ₹1,347 Cr in Q2 FY27 — strong liquidity position despite acquisition outflows
EBITDA Margin fell from 24.3% to 19.3% YoY — operating expenses rose to ₹778 Cr, outpacing revenue growth
PAT Margin declined from 16.9% to 12.8% YoY — profitability compressed despite higher top-line revenue
Shareholders Funds dropped from ₹2,528 Cr to ₹2,407 Cr YoY — likely due to acquisition-related accounting adjustments
Get forecast for Price, ROA & ROE based on analyst ratings.
JAGSNPHARM Share Price History
JAGSNPHARM Fundamentals
Company Valuation
Market Cap (₹ Cr.)
1,435
PE Ratio
31.40
PB Ratio
5.86
Dividend Yield
1.85%
ROE
15.60%
ROCE
20.30%
Book Value (₹)
36.91
Face Value (₹)
2.00
Analyse JAGSNPHARM with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 67.54% | 67.39% | 67.89% | 69.05% | 68.81% |
| Domestic Institutional Investors (DII) | 0.09% | 0.15% | 0.22% | 0.62% | 1.65% |
| Foreign Institutional Investors (FII) | 2.12% | 2.12% | 2.44% | 2.30% | 2.14% |
| Public Investors | 21.13% | 21.20% | 20.73% | 19.33% | 18.85% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Jagsonpal Pharmaceuticals Return Calculator
Note: Past profits do not guarantee future returns.
JAGSNPHARM Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
JAGSNPHARM Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for JAGSNPHARM
Margin on JAGSNPHARM
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
JAGSNPHARM Financials Summary
In Crores
JAGSNPHARM Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check JAGSNPHARM latest Company Filings, Investor Presentation & Conference Call details.
JAGSNPHARM Revenue Growth
All values are in Crores
Revenue
Profit
Loss
JAGSNPHARM Similar Stocks
FAQs on JAGSNPHARM
What is the share price of Jagsonpal Pharmaceuticals?
What is the 52W high and 52W low of Jagsonpal Pharmaceuticals?
What is the return on Jagsonpal Pharmaceuticals share?
- Past 1 year: 2.94%
- Past 3 years: 35.92%
- Past 5 years: 233.61%
What is the PE and PB Ratio of Jagsonpal Pharmaceuticals?
What is the EPS of Jagsonpal Pharmaceuticals?
What is the shareholding pattern of Jagsonpal Pharmaceuticals?
- DIIs - 1.65%
- FII - 2.14%
- Promoters - 68.81%
- Public Investors 18.85%
- Goverenment - 0.00%
How to buy Jagsonpal Pharmaceuticals shares online?
How to buy Jagsonpal Pharmaceuticals shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Jagsonpal Pharmaceuticals share
- Tap on “Buy”
